GlaxoSmithKline Intellectual Property Development Limited
发明人:
BANDYOPADHYAY, DEEPAK,EIDAM, PATRICK M.,GOUGH, PETER J.,HARRIS, PHILIP ANTHONY,JEONG, JAE U.,KANG, JIANXING,KING, BRYAN WAYNE,LAKDAWALA SHAH, AMI,MARQUIS, JR. ROBERT W.,LEISTER, LARA KATHRYN,RAHMAN, A
申请号：
PL14705891
公开号：
PL2956452T3
申请日:
2014.02.14
申请国别(地区):
PL
年份:
2018
代理人:
摘要：
Disclosed is a compound which is or a tautomer thereof or a salt thereof, pharmaceutical compositions comprising said compound or a tautomer thereof or a pharmaceutically acceptable salt thereof, and the use in the treatment of diseases/disorders which are likely to be regulated at least in part by programmed necrosis, apoptosis or the production of inflammatory cytokines.
